

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58349886 |
| 2 | signal peptide processing (GO:0006465) | 5.24109740 |
| 3 | polyketide metabolic process (GO:0030638) | 4.71172415 |
| 4 | doxorubicin metabolic process (GO:0044598) | 4.71172415 |
| 5 | daunorubicin metabolic process (GO:0044597) | 4.71172415 |
| 6 | cullin deneddylation (GO:0010388) | 4.60190523 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.56936970 |
| 8 | protein deneddylation (GO:0000338) | 4.51778791 |
| 9 | protein neddylation (GO:0045116) | 4.39414887 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.32618949 |
| 11 | cytochrome complex assembly (GO:0017004) | 4.07757749 |
| 12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.04620655 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.95528078 |
| 14 | chromatin remodeling at centromere (GO:0031055) | 3.92647755 |
| 15 | CENP-A containing nucleosome assembly (GO:0034080) | 3.85717904 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 3.85269543 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.84374683 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 3.78074739 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.78074739 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.76294708 |
| 21 | establishment of integrated proviral latency (GO:0075713) | 3.75847685 |
| 22 | response to interferon-beta (GO:0035456) | 3.75821072 |
| 23 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.74501906 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.74411764 |
| 25 | DNA deamination (GO:0045006) | 3.71903928 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.70708160 |
| 27 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.70654524 |
| 28 | protein complex biogenesis (GO:0070271) | 3.66742836 |
| 29 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.66626580 |
| 30 | negative regulation of ligase activity (GO:0051352) | 3.66626580 |
| 31 | DNA double-strand break processing (GO:0000729) | 3.59496643 |
| 32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.59268376 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50243464 |
| 34 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.48990239 |
| 35 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.47606838 |
| 36 | cotranslational protein targeting to membrane (GO:0006613) | 3.42750883 |
| 37 | respiratory burst (GO:0045730) | 3.42430225 |
| 38 | protein targeting to ER (GO:0045047) | 3.37642393 |
| 39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.36237235 |
| 40 | purine-containing compound salvage (GO:0043101) | 3.36029532 |
| 41 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.36018588 |
| 42 | myeloid dendritic cell activation (GO:0001773) | 3.33520089 |
| 43 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.33341799 |
| 44 | NADH dehydrogenase complex assembly (GO:0010257) | 3.33341799 |
| 45 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.33341799 |
| 46 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.30966436 |
| 47 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.30966436 |
| 48 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.30966436 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29566102 |
| 50 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.29393097 |
| 51 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.28807425 |
| 52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.27918937 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.27918937 |
| 54 | protein localization to endoplasmic reticulum (GO:0070972) | 3.27573692 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24630779 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24630779 |
| 57 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.22889100 |
| 58 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.22570865 |
| 59 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.22570865 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.19313203 |
| 61 | histone exchange (GO:0043486) | 3.19256646 |
| 62 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.18645686 |
| 63 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.18645686 |
| 64 | respiratory electron transport chain (GO:0022904) | 3.17947192 |
| 65 | establishment of viral latency (GO:0019043) | 3.16751956 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.16717678 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.16717678 |
| 68 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.15891982 |
| 69 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.15891982 |
| 70 | cellular response to interferon-beta (GO:0035458) | 3.15271603 |
| 71 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.14955290 |
| 72 | DNA damage response, detection of DNA damage (GO:0042769) | 3.14829941 |
| 73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.14409084 |
| 74 | protein localization to mitochondrion (GO:0070585) | 3.14289020 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.13555076 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 3.13555076 |
| 77 | positive regulation of ligase activity (GO:0051351) | 3.12791865 |
| 78 | establishment of protein localization to mitochondrion (GO:0072655) | 3.11510477 |
| 79 | electron transport chain (GO:0022900) | 3.08658696 |
| 80 | mast cell activation (GO:0045576) | 3.07267147 |
| 81 | rRNA modification (GO:0000154) | 3.05937193 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.05492606 |
| 83 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.04257709 |
| 84 | viral transcription (GO:0019083) | 3.04241453 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.03959157 |
| 86 | purine nucleobase biosynthetic process (GO:0009113) | 3.02269229 |
| 87 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.01435972 |
| 88 | pseudouridine synthesis (GO:0001522) | 3.01090980 |
| 89 | translational termination (GO:0006415) | 2.99939800 |
| 90 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.99642780 |
| 91 | protein-cofactor linkage (GO:0018065) | 2.97792852 |
| 92 | defense response to protozoan (GO:0042832) | 2.97233662 |
| 93 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.96346024 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93720484 |
| 95 | DNA replication checkpoint (GO:0000076) | 2.93131475 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 2.91532120 |
| 97 | oxidative phosphorylation (GO:0006119) | 2.91526567 |
| 98 | protein localization to kinetochore (GO:0034501) | 2.88602854 |
| 99 | regulation of ligase activity (GO:0051340) | 2.87384904 |
| 100 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.87146366 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86098246 |
| 102 | inner mitochondrial membrane organization (GO:0007007) | 2.85816868 |
| 103 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.85675712 |
| 104 | histone mRNA metabolic process (GO:0008334) | 2.82448081 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82165903 |
| 106 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.81662044 |
| 107 | telomere maintenance via recombination (GO:0000722) | 2.81444218 |
| 108 | necroptotic process (GO:0070266) | 2.80742463 |
| 109 | spliceosomal snRNP assembly (GO:0000387) | 2.79635079 |
| 110 | hydrogen ion transmembrane transport (GO:1902600) | 2.79442229 |
| 111 | DNA replication-independent nucleosome organization (GO:0034724) | 2.79422876 |
| 112 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.79422876 |
| 113 | proteasome assembly (GO:0043248) | 2.76363548 |
| 114 | GMP metabolic process (GO:0046037) | 2.76335168 |
| 115 | quinone biosynthetic process (GO:1901663) | 2.75686552 |
| 116 | ubiquinone biosynthetic process (GO:0006744) | 2.75686552 |
| 117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75535713 |
| 118 | nucleobase biosynthetic process (GO:0046112) | 2.75477779 |
| 119 | mannosylation (GO:0097502) | 2.73670458 |
| 120 | chaperone-mediated protein transport (GO:0072321) | 2.73189942 |
| 121 | endosome to pigment granule transport (GO:0043485) | 2.73002679 |
| 122 | endosome to melanosome transport (GO:0035646) | 2.73002679 |
| 123 | regulation of cellular amine metabolic process (GO:0033238) | 2.72652024 |
| 124 | organelle disassembly (GO:1903008) | 2.72315996 |
| 125 | aerobic respiration (GO:0009060) | 2.72011881 |
| 126 | superoxide anion generation (GO:0042554) | 2.67430770 |
| 127 | L-serine metabolic process (GO:0006563) | 2.67256537 |
| 128 | DNA ligation (GO:0006266) | 2.67213290 |
| 129 | mitochondrial transport (GO:0006839) | 2.66826711 |
| 130 | response to protozoan (GO:0001562) | 2.66563446 |
| 131 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.66405627 |
| 132 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.65562680 |
| 133 | reactive oxygen species biosynthetic process (GO:1903409) | 2.63974963 |
| 134 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.61354988 |
| 135 | translational elongation (GO:0006414) | 2.60652549 |
| 136 | cellular response to exogenous dsRNA (GO:0071360) | 2.60556604 |
| 137 | iron-sulfur cluster assembly (GO:0016226) | 2.60479706 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 2.60479706 |
| 139 | peptidyl-histidine modification (GO:0018202) | 2.60375390 |
| 140 | ATP biosynthetic process (GO:0006754) | 2.60295947 |
| 141 | heart contraction (GO:0060047) | 2.59792822 |
| 142 | heart process (GO:0003015) | 2.59792822 |
| 143 | regulation of mitochondrial translation (GO:0070129) | 2.59233708 |
| 144 | neutrophil activation (GO:0042119) | 2.58008592 |
| 145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54717920 |
| 146 | sequestering of metal ion (GO:0051238) | 2.53427422 |
| 147 | DNA strand elongation (GO:0022616) | 2.52423646 |
| 148 | ubiquinone metabolic process (GO:0006743) | 2.51824326 |
| 149 | intracellular pH reduction (GO:0051452) | 2.51566423 |
| 150 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.51301517 |
| 151 | dendritic cell differentiation (GO:0097028) | 2.51031103 |
| 152 | positive regulation of B cell differentiation (GO:0045579) | 2.47831796 |
| 153 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.46832068 |
| 154 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.46821209 |
| 155 | Peyers patch development (GO:0048541) | 2.43106370 |
| 156 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.43106370 |
| 157 | programmed necrotic cell death (GO:0097300) | 2.42562961 |
| 158 | platelet dense granule organization (GO:0060155) | 2.41409218 |
| 159 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.39145756 |
| 160 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38508828 |
| 161 | positive regulation of macrophage differentiation (GO:0045651) | 2.38244583 |
| 162 | protein targeting to mitochondrion (GO:0006626) | 2.38077653 |
| 163 | granulocyte activation (GO:0036230) | 2.37029655 |
| 164 | viral life cycle (GO:0019058) | 2.35622048 |
| 165 | amino acid salvage (GO:0043102) | 2.34576603 |
| 166 | L-methionine salvage (GO:0071267) | 2.34576603 |
| 167 | L-methionine biosynthetic process (GO:0071265) | 2.34576603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80860751 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.74793652 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.50353112 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.46501300 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.15128997 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.05805814 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.04517723 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91314409 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89579919 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.79301084 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.74486033 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71195073 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65016052 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53434131 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.46391344 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.44717153 |
| 17 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.43295139 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.42430587 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41942347 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39875032 |
| 21 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.39026921 |
| 22 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.36302912 |
| 23 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.33823766 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29728060 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28923273 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.24676600 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.24531952 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13235034 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.13170486 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11459703 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11069974 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.09865048 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09314679 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.02762731 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00176133 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99042512 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95527879 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93811998 |
| 39 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91565819 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90433745 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88758839 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.87222038 |
| 43 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84264144 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81722593 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81530247 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80700555 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80112449 |
| 48 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.78209935 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74564532 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.72870186 |
| 51 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71456943 |
| 52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.70855504 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69192723 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67609380 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66736444 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66343136 |
| 57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65516495 |
| 58 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.61944025 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60383175 |
| 60 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.58192775 |
| 61 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56873408 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54703101 |
| 63 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54090413 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.53729306 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48527490 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45652776 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43236807 |
| 68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42049045 |
| 69 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40089181 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39715478 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.39100833 |
| 72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37657953 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36072748 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.34679388 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.33080055 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31640153 |
| 77 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30359332 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26932752 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26140348 |
| 80 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23788956 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.22885661 |
| 82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22507541 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20832681 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18603992 |
| 85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17568410 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16880191 |
| 87 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.15466380 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15274419 |
| 89 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14846877 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14697925 |
| 91 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14413519 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13900725 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13370801 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13331819 |
| 95 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12603448 |
| 96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12425738 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12129151 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10635804 |
| 99 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.09633045 |
| 100 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.08850246 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08062301 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07816369 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07293880 |
| 104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07196269 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07090109 |
| 106 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06642503 |
| 107 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06301557 |
| 108 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06199295 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06126461 |
| 110 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04393795 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03087359 |
| 112 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02727177 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01834394 |
| 114 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01760837 |
| 115 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01527932 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01523588 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00529782 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99109996 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99033589 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 0.98559233 |
| 121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98552859 |
| 122 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97336528 |
| 123 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97241755 |
| 124 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96712347 |
| 125 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.94617439 |
| 126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93305388 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92668879 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92581330 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92432046 |
| 130 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90636992 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90289894 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89823396 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88461008 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87944742 |
| 135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87672516 |
| 136 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87584568 |
| 137 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.87500534 |
| 138 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87001352 |
| 139 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86848867 |
| 140 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86777149 |
| 141 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86069081 |
| 142 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86068698 |
| 143 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85550395 |
| 144 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85550395 |
| 145 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84490706 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83843379 |
| 147 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83089147 |
| 148 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.82776084 |
| 149 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.82386848 |
| 150 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82044853 |
| 151 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79324962 |
| 152 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77675452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.90812358 |
| 2 | MP0008058_abnormal_DNA_repair | 3.49314700 |
| 3 | MP0002102_abnormal_ear_morphology | 3.17094025 |
| 4 | MP0005671_abnormal_response_to | 3.06722294 |
| 5 | MP0009785_altered_susceptibility_to | 3.02605266 |
| 6 | MP0008877_abnormal_DNA_methylation | 2.98881569 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.86305564 |
| 8 | MP0004147_increased_porphyrin_level | 2.84023215 |
| 9 | MP0003724_increased_susceptibility_to | 2.82421276 |
| 10 | MP0003646_muscle_fatigue | 2.66174978 |
| 11 | MP0003436_decreased_susceptibility_to | 2.62047236 |
| 12 | MP0000685_abnormal_immune_system | 2.55248340 |
| 13 | MP0001529_abnormal_vocalization | 2.53864638 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.53064315 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.44609843 |
| 16 | MP0005025_abnormal_response_to | 2.38228786 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.33026075 |
| 18 | MP0003787_abnormal_imprinting | 2.25453738 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.23812493 |
| 20 | MP0003718_maternal_effect | 2.22347367 |
| 21 | MP0002419_abnormal_innate_immunity | 2.20364147 |
| 22 | MP0005387_immune_system_phenotype | 2.17657778 |
| 23 | MP0001790_abnormal_immune_system | 2.17657778 |
| 24 | MP0001984_abnormal_olfaction | 2.14074209 |
| 25 | MP0001800_abnormal_humoral_immune | 2.08379299 |
| 26 | MP0002723_abnormal_immune_serum | 2.07266586 |
| 27 | MP0003111_abnormal_nucleus_morphology | 2.07121446 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.03903768 |
| 29 | MP0001853_heart_inflammation | 2.02621090 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.94273530 |
| 31 | MP0001819_abnormal_immune_cell | 1.93014576 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.91392525 |
| 33 | * MP0006036_abnormal_mitochondrial_physio | 1.88584676 |
| 34 | MP0003121_genomic_imprinting | 1.86186387 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.84585321 |
| 36 | MP0006082_CNS_inflammation | 1.80259011 |
| 37 | MP0008007_abnormal_cellular_replicative | 1.80128817 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.77581788 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.76324082 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.74595792 |
| 41 | MP0003123_paternal_imprinting | 1.72005848 |
| 42 | MP0002398_abnormal_bone_marrow | 1.70201078 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.70151326 |
| 44 | MP0003077_abnormal_cell_cycle | 1.69679530 |
| 45 | MP0009046_muscle_twitch | 1.67218072 |
| 46 | MP0002938_white_spotting | 1.63783068 |
| 47 | MP0003186_abnormal_redox_activity | 1.63553629 |
| 48 | MP0003122_maternal_imprinting | 1.63473307 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 1.62980885 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.62221087 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.61989799 |
| 52 | MP0003011_delayed_dark_adaptation | 1.61773533 |
| 53 | MP0000716_abnormal_immune_system | 1.59286318 |
| 54 | MP0002736_abnormal_nociception_after | 1.57032497 |
| 55 | MP0002163_abnormal_gland_morphology | 1.55923771 |
| 56 | MP0001764_abnormal_homeostasis | 1.55638548 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.55623133 |
| 58 | MP0004510_myositis | 1.55393324 |
| 59 | MP0001293_anophthalmia | 1.55274212 |
| 60 | MP0006054_spinal_hemorrhage | 1.54581784 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.51003416 |
| 62 | MP0008469_abnormal_protein_level | 1.49468659 |
| 63 | MP0001188_hyperpigmentation | 1.48774219 |
| 64 | MP0008004_abnormal_stomach_pH | 1.48750688 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.43963822 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.43396698 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.42812624 |
| 68 | MP0002429_abnormal_blood_cell | 1.40942024 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.39252209 |
| 70 | MP0000343_altered_response_to | 1.39152686 |
| 71 | * MP0003786_premature_aging | 1.38174816 |
| 72 | MP0005253_abnormal_eye_physiology | 1.37740521 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.35935143 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.32140974 |
| 75 | MP0002722_abnormal_immune_system | 1.31159204 |
| 76 | MP0010386_abnormal_urinary_bladder | 1.27357936 |
| 77 | * MP0002090_abnormal_vision | 1.23028006 |
| 78 | MP0008057_abnormal_DNA_replication | 1.22830323 |
| 79 | MP0004142_abnormal_muscle_tone | 1.22491716 |
| 80 | MP0002405_respiratory_system_inflammati | 1.22279194 |
| 81 | MP0002095_abnormal_skin_pigmentation | 1.21747340 |
| 82 | MP0005394_taste/olfaction_phenotype | 1.21564881 |
| 83 | MP0005499_abnormal_olfactory_system | 1.21564881 |
| 84 | MP0004043_abnormal_pH_regulation | 1.21385281 |
| 85 | MP0005332_abnormal_amino_acid | 1.19778084 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19659219 |
| 87 | MP0003195_calcinosis | 1.19328195 |
| 88 | MP0003303_peritoneal_inflammation | 1.19230764 |
| 89 | MP0009697_abnormal_copulation | 1.17423833 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 1.16252356 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 1.16168372 |
| 92 | MP0003941_abnormal_skin_development | 1.15355492 |
| 93 | MP0004215_abnormal_myocardial_fiber | 1.15195703 |
| 94 | MP0010155_abnormal_intestine_physiology | 1.15088651 |
| 95 | MP0002735_abnormal_chemical_nociception | 1.13908242 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 1.13512624 |
| 97 | MP0009764_decreased_sensitivity_to | 1.13006252 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 1.12954569 |
| 99 | MP0001968_abnormal_touch/_nociception | 1.12784007 |
| 100 | MP0001533_abnormal_skeleton_physiology | 1.12234996 |
| 101 | MP0001324_abnormal_eye_pigmentation | 1.09681049 |
| 102 | * MP0000358_abnormal_cell_content/ | 1.09611133 |
| 103 | * MP0003866_abnormal_defecation | 1.09340564 |
| 104 | MP0000490_abnormal_crypts_of | 1.09325794 |
| 105 | MP0002166_altered_tumor_susceptibility | 1.09323119 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06369602 |
| 107 | MP0002751_abnormal_autonomic_nervous | 1.06282064 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 1.06210163 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 1.05069352 |
| 110 | MP0005174_abnormal_tail_pigmentation | 1.04263683 |
| 111 | MP0001905_abnormal_dopamine_level | 1.04218989 |
| 112 | MP0002160_abnormal_reproductive_system | 1.03611377 |
| 113 | MP0002272_abnormal_nervous_system | 1.03318130 |
| 114 | MP0002006_tumorigenesis | 1.03138319 |
| 115 | * MP0002693_abnormal_pancreas_physiology | 1.02773836 |
| 116 | MP0005058_abnormal_lysosome_morphology | 1.02517723 |
| 117 | MP0002210_abnormal_sex_determination | 1.02357108 |
| 118 | MP0004133_heterotaxia | 1.01506233 |
| 119 | MP0002638_abnormal_pupillary_reflex | 1.00175361 |
| 120 | MP0008872_abnormal_physiological_respon | 0.99318681 |
| 121 | MP0003136_yellow_coat_color | 0.98892607 |
| 122 | MP0008995_early_reproductive_senescence | 0.98787243 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.98559549 |
| 124 | MP0000647_abnormal_sebaceous_gland | 0.98375205 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.98237637 |
| 126 | MP0001545_abnormal_hematopoietic_system | 0.96962592 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.96962592 |
| 128 | MP0005310_abnormal_salivary_gland | 0.96192842 |
| 129 | MP0001929_abnormal_gametogenesis | 0.93579763 |
| 130 | MP0005408_hypopigmentation | 0.92745430 |
| 131 | MP0009745_abnormal_behavioral_response | 0.90403857 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.89878298 |
| 133 | MP0001873_stomach_inflammation | 0.89872722 |
| 134 | MP0000653_abnormal_sex_gland | 0.89503764 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.88574533 |
| 136 | MP0002933_joint_inflammation | 0.88077224 |
| 137 | MP0003693_abnormal_embryo_hatching | 0.87225126 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.87096114 |
| 139 | MP0003880_abnormal_central_pattern | 0.86879596 |
| 140 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86802643 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.86469527 |
| 142 | MP0008775_abnormal_heart_ventricle | 0.85384413 |
| 143 | MP0005389_reproductive_system_phenotype | 0.85337982 |
| 144 | MP0001145_abnormal_male_reproductive | 0.85129640 |
| 145 | MP0004084_abnormal_cardiac_muscle | 0.85106406 |
| 146 | MP0001663_abnormal_digestive_system | 0.84917308 |
| 147 | MP0003828_pulmonary_edema | 0.84674977 |
| 148 | MP0001879_abnormal_lymphatic_vessel | 0.84650472 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.84456592 |
| 150 | MP0000703_abnormal_thymus_morphology | 0.83004626 |
| 151 | MP0002653_abnormal_ependyma_morphology | 0.81401106 |
| 152 | * MP0006035_abnormal_mitochondrial_morpho | 0.81114295 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.80140459 |
| 154 | MP0008260_abnormal_autophagy | 0.80114632 |
| 155 | MP0000631_abnormal_neuroendocrine_gland | 0.79606224 |
| 156 | MP0005645_abnormal_hypothalamus_physiol | 0.79286510 |
| 157 | MP0005410_abnormal_fertilization | 0.75905207 |
| 158 | MP0003868_abnormal_feces_composition | 0.73796439 |
| 159 | MP0000681_abnormal_thyroid_gland | 0.73689462 |
| 160 | MP0000015_abnormal_ear_pigmentation | 0.73682812 |
| 161 | MP0010094_abnormal_chromosome_stability | 0.71651290 |
| 162 | MP0004036_abnormal_muscle_relaxation | 0.71406297 |
| 163 | MP0002138_abnormal_hepatobiliary_system | 0.71225624 |
| 164 | MP0005646_abnormal_pituitary_gland | 0.70927974 |
| 165 | MP0003698_abnormal_male_reproductive | 0.70903119 |
| 166 | MP0005266_abnormal_metabolism | 0.70753787 |
| 167 | MP0000372_irregular_coat_pigmentation | 0.70463352 |
| 168 | MP0003937_abnormal_limbs/digits/tail_de | 0.68752509 |
| 169 | MP0005391_vision/eye_phenotype | 0.68346895 |
| 170 | MP0005395_other_phenotype | 0.67726424 |
| 171 | * MP0002229_neurodegeneration | 0.66921804 |
| 172 | MP0002233_abnormal_nose_morphology | 0.66851224 |
| 173 | MP0001697_abnormal_embryo_size | 0.66258294 |
| 174 | MP0001919_abnormal_reproductive_system | 0.65009921 |
| 175 | MP0001119_abnormal_female_reproductive | 0.64978942 |
| 176 | MP0002139_abnormal_hepatobiliary_system | 0.64535959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 4.55808242 |
| 2 | Hepatic necrosis (HP:0002605) | 4.47451436 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.06027254 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.02088088 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.00669916 |
| 6 | Increased CSF lactate (HP:0002490) | 3.69134380 |
| 7 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.53231612 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.53231612 |
| 9 | Acute encephalopathy (HP:0006846) | 3.47480001 |
| 10 | Generalized aminoaciduria (HP:0002909) | 3.39446400 |
| 11 | Increased intramyocellular lipid droplets (HP:0012240) | 3.36539665 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.34752929 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.34741527 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.32734189 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 3.30846689 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.29853968 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.05702691 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00680277 |
| 19 | Hyperalaninemia (HP:0003348) | 2.99562194 |
| 20 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.99562194 |
| 21 | Abnormality of alanine metabolism (HP:0010916) | 2.99562194 |
| 22 | Thrombocytosis (HP:0001894) | 2.96253937 |
| 23 | Increased serum lactate (HP:0002151) | 2.95520806 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.93198555 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 2.90956098 |
| 26 | Eczematoid dermatitis (HP:0000976) | 2.89686787 |
| 27 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.89671386 |
| 28 | Lactic acidosis (HP:0003128) | 2.85201055 |
| 29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.78713547 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.77655485 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.76570704 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73389316 |
| 33 | Degeneration of anterior horn cells (HP:0002398) | 2.71210514 |
| 34 | Abnormality of the anterior horn cell (HP:0006802) | 2.71210514 |
| 35 | Aplastic anemia (HP:0001915) | 2.71199421 |
| 36 | Exertional dyspnea (HP:0002875) | 2.68025831 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.67133213 |
| 38 | Hyperglycinemia (HP:0002154) | 2.65099305 |
| 39 | 3-Methylglutaconic aciduria (HP:0003535) | 2.64974670 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64194325 |
| 41 | Myositis (HP:0100614) | 2.62943364 |
| 42 | Exercise intolerance (HP:0003546) | 2.62929725 |
| 43 | Increased serum pyruvate (HP:0003542) | 2.58242426 |
| 44 | Abnormality of glycolysis (HP:0004366) | 2.58242426 |
| 45 | Chronic otitis media (HP:0000389) | 2.54596638 |
| 46 | Neoplasm of head and neck (HP:0012288) | 2.52091374 |
| 47 | Esophageal neoplasm (HP:0100751) | 2.52091374 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.49242343 |
| 49 | IgM deficiency (HP:0002850) | 2.47642513 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.45106768 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.45105237 |
| 52 | Hypothermia (HP:0002045) | 2.44266331 |
| 53 | Microvesicular hepatic steatosis (HP:0001414) | 2.43257918 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 2.42559153 |
| 55 | Cerebral edema (HP:0002181) | 2.40736820 |
| 56 | Lethargy (HP:0001254) | 2.39569403 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.37813257 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.34076848 |
| 59 | Respiratory failure (HP:0002878) | 2.33529291 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.29791955 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29537564 |
| 62 | Colon cancer (HP:0003003) | 2.28812032 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.25709891 |
| 64 | Leukodystrophy (HP:0002415) | 2.24786469 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23727721 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.21896162 |
| 67 | B lymphocytopenia (HP:0010976) | 2.21896162 |
| 68 | Poor head control (HP:0002421) | 2.20436433 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 2.19823329 |
| 70 | Abnormality of midbrain morphology (HP:0002418) | 2.19823329 |
| 71 | Optic disc pallor (HP:0000543) | 2.17631489 |
| 72 | Petechiae (HP:0000967) | 2.17078547 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.16269431 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.16269431 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.16269431 |
| 76 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.16269431 |
| 77 | Congenital primary aphakia (HP:0007707) | 2.15705878 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.14265488 |
| 79 | Recurrent viral infections (HP:0004429) | 2.14206822 |
| 80 | Respiratory difficulties (HP:0002880) | 2.12787936 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.12390233 |
| 82 | Gait imbalance (HP:0002141) | 2.11010962 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.10410062 |
| 84 | Glycosuria (HP:0003076) | 2.08983310 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.08983310 |
| 86 | Recurrent skin infections (HP:0001581) | 2.08808927 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08180967 |
| 88 | Macrocytic anemia (HP:0001972) | 2.06956408 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.06192728 |
| 90 | Cerebral hypomyelination (HP:0006808) | 2.04214592 |
| 91 | Pallor (HP:0000980) | 2.04128113 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 2.03117802 |
| 93 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02920790 |
| 94 | Hypoproteinemia (HP:0003075) | 2.02760263 |
| 95 | CNS demyelination (HP:0007305) | 2.01782006 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 1.95706752 |
| 97 | Optic neuritis (HP:0100653) | 1.95706752 |
| 98 | Recurrent fungal infections (HP:0002841) | 1.95253585 |
| 99 | Pancytopenia (HP:0001876) | 1.95035103 |
| 100 | Recurrent pneumonia (HP:0006532) | 1.92622464 |
| 101 | Meckel diverticulum (HP:0002245) | 1.92214711 |
| 102 | Hyperphosphaturia (HP:0003109) | 1.91761878 |
| 103 | Obstructive lung disease (HP:0006536) | 1.91724403 |
| 104 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91724403 |
| 105 | Severe visual impairment (HP:0001141) | 1.91338205 |
| 106 | Palpitations (HP:0001962) | 1.91131695 |
| 107 | Chromsome breakage (HP:0040012) | 1.91010727 |
| 108 | X-linked dominant inheritance (HP:0001423) | 1.90192094 |
| 109 | Meningitis (HP:0001287) | 1.90111614 |
| 110 | Orchitis (HP:0100796) | 1.88072071 |
| 111 | Epistaxis (HP:0000421) | 1.87778848 |
| 112 | Gliosis (HP:0002171) | 1.87576465 |
| 113 | Abnormality of vitamin B metabolism (HP:0004340) | 1.86458253 |
| 114 | Abnormality of chromosome stability (HP:0003220) | 1.85903050 |
| 115 | Poor suck (HP:0002033) | 1.85598890 |
| 116 | Pancreatic cysts (HP:0001737) | 1.84880968 |
| 117 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.84782837 |
| 118 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.84359295 |
| 119 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83956278 |
| 120 | Agnosia (HP:0010524) | 1.83532525 |
| 121 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.82840736 |
| 122 | Vasculitis (HP:0002633) | 1.82745127 |
| 123 | Abnormality of the ileum (HP:0001549) | 1.82131940 |
| 124 | Prolonged bleeding time (HP:0003010) | 1.82010582 |
| 125 | Neutropenia (HP:0001875) | 1.81640760 |
| 126 | Hypoglycemic coma (HP:0001325) | 1.81323403 |
| 127 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80640458 |
| 128 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80320842 |
| 129 | Megaloblastic anemia (HP:0001889) | 1.79637069 |
| 130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78984701 |
| 131 | Dicarboxylic aciduria (HP:0003215) | 1.78984701 |
| 132 | Pheochromocytoma (HP:0002666) | 1.78981361 |
| 133 | Methylmalonic acidemia (HP:0002912) | 1.78404328 |
| 134 | Sclerocornea (HP:0000647) | 1.76444638 |
| 135 | Reticulocytopenia (HP:0001896) | 1.75978848 |
| 136 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.75537492 |
| 137 | Renal cortical cysts (HP:0000803) | 1.75185622 |
| 138 | Hypoplasia of the thymus (HP:0000778) | 1.74212068 |
| 139 | True hermaphroditism (HP:0010459) | 1.73903942 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.73599608 |
| 141 | Abnormality of glycine metabolism (HP:0010895) | 1.73154983 |
| 142 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73154983 |
| 143 | Neoplasm of the adrenal gland (HP:0100631) | 1.70689539 |
| 144 | Abnormality of the preputium (HP:0100587) | 1.69408182 |
| 145 | CNS hypomyelination (HP:0003429) | 1.69144307 |
| 146 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.68524632 |
| 147 | Cortical dysplasia (HP:0002539) | 1.68355565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.23621522 |
| 2 | STK16 | 3.09739838 |
| 3 | TXK | 2.94698075 |
| 4 | VRK2 | 2.83289912 |
| 5 | NME2 | 2.65776043 |
| 6 | TRIM28 | 2.58644442 |
| 7 | IRAK4 | 2.50886728 |
| 8 | NEK1 | 2.35632481 |
| 9 | EIF2AK1 | 2.23146930 |
| 10 | MAP4K2 | 2.16230096 |
| 11 | VRK1 | 2.13261059 |
| 12 | TEC | 2.08299630 |
| 13 | PLK3 | 2.04613100 |
| 14 | KIT | 2.02606502 |
| 15 | WNK3 | 2.01811137 |
| 16 | PIM2 | 1.99610886 |
| 17 | CDC7 | 1.99533035 |
| 18 | MAP4K1 | 1.99324642 |
| 19 | MUSK | 1.97982548 |
| 20 | MAP3K14 | 1.96118358 |
| 21 | BCR | 1.93277088 |
| 22 | CDK19 | 1.92173559 |
| 23 | PIK3CG | 1.88940648 |
| 24 | CDK8 | 1.87945618 |
| 25 | EIF2AK3 | 1.87308085 |
| 26 | TBK1 | 1.84881345 |
| 27 | CASK | 1.76999418 |
| 28 | SIK3 | 1.73025676 |
| 29 | TTK | 1.68413542 |
| 30 | CCNB1 | 1.67145008 |
| 31 | CAMKK2 | 1.66303437 |
| 32 | BRSK2 | 1.65778139 |
| 33 | MST4 | 1.63299027 |
| 34 | PBK | 1.62687486 |
| 35 | TSSK6 | 1.56600219 |
| 36 | IRAK3 | 1.53994908 |
| 37 | IKBKE | 1.53747462 |
| 38 | TNIK | 1.53367800 |
| 39 | MKNK2 | 1.48835105 |
| 40 | MAP3K12 | 1.41417864 |
| 41 | BLK | 1.41162815 |
| 42 | SCYL2 | 1.41048185 |
| 43 | ZAP70 | 1.38810494 |
| 44 | PLK2 | 1.34040087 |
| 45 | SYK | 1.32757356 |
| 46 | CSNK1G3 | 1.31699675 |
| 47 | PLK1 | 1.31685352 |
| 48 | BTK | 1.31203974 |
| 49 | NEK9 | 1.30702836 |
| 50 | TAF1 | 1.29223026 |
| 51 | DYRK2 | 1.26435801 |
| 52 | WEE1 | 1.25803804 |
| 53 | BCKDK | 1.23773189 |
| 54 | CSNK1G2 | 1.22762876 |
| 55 | JAK3 | 1.22351410 |
| 56 | TYK2 | 1.20830630 |
| 57 | LIMK1 | 1.20361546 |
| 58 | MYLK | 1.20277854 |
| 59 | FRK | 1.18905877 |
| 60 | TLK1 | 1.18626019 |
| 61 | FLT3 | 1.18374912 |
| 62 | NME1 | 1.14811748 |
| 63 | RIPK4 | 1.13862202 |
| 64 | MAP2K7 | 1.12571107 |
| 65 | CSNK1G1 | 1.11855560 |
| 66 | MAP3K4 | 1.09298497 |
| 67 | DYRK3 | 1.06810047 |
| 68 | MAPKAPK5 | 1.06556947 |
| 69 | MAP2K3 | 1.05526323 |
| 70 | IKBKB | 1.03088770 |
| 71 | TGFBR1 | 1.02804836 |
| 72 | ERBB3 | 0.99627347 |
| 73 | CSNK1A1L | 0.99377941 |
| 74 | SRPK1 | 0.99131460 |
| 75 | IRAK1 | 0.98844651 |
| 76 | LYN | 0.98671211 |
| 77 | RPS6KA4 | 0.97917277 |
| 78 | YES1 | 0.96126911 |
| 79 | PIK3CA | 0.93162300 |
| 80 | FES | 0.93140938 |
| 81 | TIE1 | 0.92475057 |
| 82 | TAOK3 | 0.89187544 |
| 83 | STK39 | 0.89103469 |
| 84 | INSRR | 0.86115388 |
| 85 | TESK1 | 0.84210717 |
| 86 | TGFBR2 | 0.83582705 |
| 87 | MINK1 | 0.83275945 |
| 88 | BMPR1B | 0.81263926 |
| 89 | OBSCN | 0.80179564 |
| 90 | IRAK2 | 0.78446721 |
| 91 | GRK1 | 0.77605313 |
| 92 | MKNK1 | 0.77411340 |
| 93 | BMPR2 | 0.76295416 |
| 94 | LCK | 0.74923711 |
| 95 | ARAF | 0.74244615 |
| 96 | OXSR1 | 0.73842304 |
| 97 | ADRBK2 | 0.72960005 |
| 98 | DAPK1 | 0.72728360 |
| 99 | ATR | 0.71347344 |
| 100 | PASK | 0.71101151 |
| 101 | PRKCG | 0.70502498 |
| 102 | TESK2 | 0.69443829 |
| 103 | AURKB | 0.69377590 |
| 104 | TNK2 | 0.68753617 |
| 105 | GRK5 | 0.65993747 |
| 106 | EIF2AK2 | 0.65609718 |
| 107 | MATK | 0.63776201 |
| 108 | CHEK2 | 0.63381820 |
| 109 | AURKA | 0.62013195 |
| 110 | STK38L | 0.60865967 |
| 111 | NLK | 0.59785366 |
| 112 | KDR | 0.57825456 |
| 113 | BRSK1 | 0.56454413 |
| 114 | ACVR1B | 0.56178249 |
| 115 | ABL2 | 0.55296205 |
| 116 | CSNK2A2 | 0.54430483 |
| 117 | ATM | 0.52250269 |
| 118 | ITK | 0.51792317 |
| 119 | STK3 | 0.51604232 |
| 120 | PRKCE | 0.51417451 |
| 121 | PLK4 | 0.50122460 |
| 122 | PIM1 | 0.49523481 |
| 123 | GRK7 | 0.48904074 |
| 124 | NUAK1 | 0.47831605 |
| 125 | JAK1 | 0.47803613 |
| 126 | WNK4 | 0.47296949 |
| 127 | CDK3 | 0.45750610 |
| 128 | PAK3 | 0.45147038 |
| 129 | PDK2 | 0.44975647 |
| 130 | MAPK15 | 0.44009144 |
| 131 | PRKG2 | 0.42093476 |
| 132 | TRPM7 | 0.41779789 |
| 133 | HIPK2 | 0.41572684 |
| 134 | MAPK12 | 0.40266895 |
| 135 | RPS6KA5 | 0.39957101 |
| 136 | CDK14 | 0.38853658 |
| 137 | NEK2 | 0.37909962 |
| 138 | CSNK1A1 | 0.37533292 |
| 139 | JAK2 | 0.37287763 |
| 140 | CAMK1 | 0.36585938 |
| 141 | CAMK2A | 0.34739610 |
| 142 | ZAK | 0.34691085 |
| 143 | CSF1R | 0.33750408 |
| 144 | LMTK2 | 0.33710035 |
| 145 | MAPK13 | 0.33527714 |
| 146 | PINK1 | 0.33407493 |
| 147 | CSNK1E | 0.33340193 |
| 148 | ADRBK1 | 0.33145990 |
| 149 | CSNK2A1 | 0.32053383 |
| 150 | CDK18 | 0.31243880 |
| 151 | NEK6 | 0.31015228 |
| 152 | STK4 | 0.29343771 |
| 153 | ALK | 0.29122849 |
| 154 | MAP3K5 | 0.29010798 |
| 155 | EPHA4 | 0.27945092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.36646999 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.55432802 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.48815892 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.21207622 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.82696667 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.81341057 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.61809723 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.23984225 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.08139359 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.07762264 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.01018974 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95757424 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.95725118 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75403847 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74834543 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.71578065 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69388165 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.65541892 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57349290 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.55517897 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.54909452 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53851522 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.53636010 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49376536 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48532210 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46513676 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46018027 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.45475430 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.45440302 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43064172 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40474560 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.38999108 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.38853366 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38610074 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36459841 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33681591 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30541991 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23217326 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.20893318 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19945990 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19659583 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18743076 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17531436 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.16653747 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16504675 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14586151 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 1.13038951 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12834068 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.11534313 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11324365 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10533244 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09308181 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09054561 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.08246183 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06090262 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04358570 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02272317 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02086089 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99803636 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99528815 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96959589 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95619954 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95289573 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.93954801 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93041917 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.92547476 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.91096969 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91002905 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89017133 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88853352 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88300600 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82945955 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81541590 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.80751102 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78326631 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76262389 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75958633 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70575167 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70568723 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70255508 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69718175 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69273249 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.68777689 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.68192092 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.68067814 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67346042 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67204513 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66437325 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65964086 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65094940 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64770512 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63009509 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62717634 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61758738 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60603471 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60240198 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57683764 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57125071 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57021252 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56348130 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55612883 |
| 102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55319859 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.54720764 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53986302 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53333030 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53035755 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52977683 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52955550 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.52835522 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52367059 |
| 111 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51364868 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51270044 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.50643677 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49799317 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49715986 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49224490 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47873730 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47188216 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46236711 |
| 120 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45991627 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45947998 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45903559 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45369933 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44745147 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44489762 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43837363 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43674879 |
| 128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43381476 |
| 129 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38237721 |
| 130 | Apoptosis_Homo sapiens_hsa04210 | 0.37925437 |
| 131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37525273 |
| 132 | Phototransduction_Homo sapiens_hsa04744 | 0.36877719 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35863422 |
| 134 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33599313 |
| 135 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32369682 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31271290 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30557112 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30129431 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29690304 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27787582 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.27093198 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26767202 |
| 143 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26566721 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26327050 |
| 145 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25368713 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.23583582 |

